Dr. Jeffrey DeClaire - OMNIBotics resection
OMNIlife science™, Inc. Achieves Milestone with OMNIBotics® Active Spacer
1,000 Cases Completed with First Predictive Ligament Balancing Robot
AYNHAM, Mass., Oct. 3, 2018 /PRNewswire/ -- OMNIlife science, Inc. ("OMNI"), a privately-held, medical technology company targeting the $15 billion global hip and knee replacement device market, reported today that the positive clinical benefits of the OMNIBotics® Robotic Active Spacer continue to be reinforced by more than 1,000 successful procedures performed to date. Orthopaedic surgeons have been evaluating this revolutionary system that utilizes a miniature robot to ensure the ligaments will be "balanced" after the knee replacement.
Please Join us for a Candid Discussion on Options in Total Knee Replacement - Given by Dr. Jeffrey H. DeClaire, MD
Jeffrey H. DeClaire, M.D. is a board-certified and fellowship trained orthopaedic surgeon. Dr. DeClaire has practiced orthopaedic surgery in Rochester, MI for more than 25 years and specializes in the treatment of disorders and injuries of the knee. He is the Co-Founder and President of the DeClaire LaMacchia Orthopaedic Institute, the Chief of the department of Orthopaedics and Surgery at Ascension Providence Rochester Hospital and is an associate clinical professor at Oakland University in Rochester Hills, MI. Dr. DeClaire is an industry leader in bringing new technologies for the treatment and benefit of his patients.
Dr. Jeffrey DeClaire - Background and Education. Knee Surgery - Knee Replacement Detroit, MI.
Dr. Jeffrey DeClaire & Dr. John LaMacchia Knee Surgeon - Knee Surgery Detroit, MI.
Apple hopes the Apple Watch can help patients recover faster from knee and hip replacements
As Apple pushes deeper into health care with the Apple Watch, the company is developing a plan to help people who are recovering from knee and hip replacement surgeries.